Why the study?
Are urinary Prothrombin Fragment 1+2 (uF1+2) levels associated with the development of venous thromboembolism after total knee replacement?
Are urinary Prothrombin Fragment 1+2 (uF1+2) levels associated with the development of venous thromboembolism after total knee replacement?
Answers are grounded in this paper and cite their sources.
Urinary Prothrombin Fragment 1+2 levels are significantly elevated in patients who develop VTE after total knee replacement, suggesting its potential as a non-invasive biomarker for VTE risk.
Prothrombin fragment 1+2 is excreted in urine (uF1+2) as a result of in vivo thrombin generation and can be a marker of coagulation status after an operative procedure. This study compared uF1+2 levels in patients with symptomatic and non-symptomatic venous thromboembolism (VTE) after total knee replacement (TKR) and in event-free sex- and age-matched controls. Significantly higher median uF1+2 levels were seen in the VTE patients on days 1, 3, and the day of venography (mostly day 7) after TKR compared with controls. The uF1+2 levels tended to be high in some patients with symptomatic VTE; however, the discriminatory efficacy of the test could not be evaluated. In conclusion, this study showed that patients with VTE tend to have significantly higher uF1+2 levels compared with patients without events between days 1 and 7 after TKR surgery. Measurement of uF1+2 could provide a simple, non-invasive clinical test to identify patients at risk of VTE.
No takes yet. Share an insight, caveat, or question.
Borris et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: